Comparison of Postoperative Delirium in Elders Anaesthetised With Midazolam and Without Midazolam

NCT05456230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11927

Last updated 2022-07-18

No results posted yet for this study

Summary

This research project is an observational cohort study by prospective chart review of patients that underwent surgery in multi-centers, China, in the years 2020-2022. The purpose of this study is to compare the occurrence of postoperative delirium With Midazolam and Without Midazolam During Non-cardiac Surgery in Elders.

Conditions

  • Postoperative Delirium

Interventions

DRUG

Midazolam

Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER
  • Peking University First Hospital

    collaborator OTHER
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • China-Japan Friendship Hospital

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Central South University

    collaborator OTHER
  • Peking University People's Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • Sun Yat-sen University

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Taihe Hospital

    collaborator OTHER
  • The Affiliated Hospital Of Guizhou Medical University

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • Zhejiang Provincial People's Hospital

    collaborator OTHER
  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Weidong Mi, PhD · Chinese PLA General Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2022-04-30
Completion
2022-07-11

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05456230 on ClinicalTrials.gov